Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Leukemia · 2024 · PMC11147761 · PMID 38493239

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

We observed significantly decreased expression of important molecular targets that are currently in use for MM treatment ( CD38, SLAMF7 , and GPRC5D ) and a strong trend of lower expression for FCRH5 (Fig. 5 ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.